These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29383513)

  • 21. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
    Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
    Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and genetic characterization of an Italian family with slow-channel syndrome.
    Angelini C; Lispi L; Salvoro C; Mostacciuolo ML; Vazza G
    Neurol Sci; 2019 Mar; 40(3):503-507. PubMed ID: 30542963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homozygous Duplication in the
    Almatrafi AM; Alluqmani MM; Basit S
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel phenotype of AChR-deficiency syndrome with predominant facial and distal weakness resulting from the inclusion of an evolutionary alternatively-spliced exon in CHRNA1.
    Rodríguez Cruz PM; Ravenscroft G; Natera D; Carr A; Manzur A; Liu WW; Vella NR; Jericó I; Gonzalez-Quereda L; Gallano P; Montalto SA; Davis MR; Lamont PJ; Laing NG; Bourque P; Nascimento A; Muntoni F; Polavarapu K; Lochmüller H; Palace J; Beeson D
    Neuromuscul Disord; 2023 Feb; 33(2):161-168. PubMed ID: 36634413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations.
    Natera-de Benito D; Bestué M; Vilchez JJ; Evangelista T; Töpf A; García-Ribes A; Trujillo-Tiebas MJ; García-Hoyos M; Ortez C; Camacho A; Jiménez E; Dusl M; Abicht A; Lochmüller H; Colomer J; Nascimento A
    Neuromuscul Disord; 2016 Feb; 26(2):153-9. PubMed ID: 26782015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
    Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
    Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of congenital myasthenic syndromes in Spain.
    Natera-de Benito D; Töpf A; Vilchez JJ; González-Quereda L; Domínguez-Carral J; Díaz-Manera J; Ortez C; Bestué M; Gallano P; Dusl M; Abicht A; Müller JS; Senderek J; García-Ribes A; Muelas N; Evangelista T; Azuma Y; McMacken G; Paipa Merchan A; Rodríguez Cruz PM; Camacho A; Jiménez E; Miranda-Herrero MC; Santana-Artiles A; García-Campos O; Dominguez-Rubio R; Olivé M; Colomer J; Beeson D; Lochmüller H; Nascimento A
    Neuromuscul Disord; 2017 Dec; 27(12):1087-1098. PubMed ID: 29054425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delineation of molecular characteristics of congenital myasthenic syndromes in Indian families and review of literature.
    Mishra S; Nair KV; Shukla A
    Clin Dysmorphol; 2023 Oct; 32(4):162-167. PubMed ID: 37646703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital myasthenic syndrome due to DOK7 mutation in a cohort of patients with 'unexplained' limb-girdle muscular weakness.
    Lorenzoni PJ; Kay CSK; Arndt RC; Hrysay NMC; Ducci RD; Fustes OHJ; Töpf A; Lochmüller H; Werneck LC; Scola RH
    J Clin Neurosci; 2020 May; 75():195-198. PubMed ID: 32238315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and clinical evaluation of congenital myasthenic syndromes with long-term follow-up: experience of a tertiary center in Turkey.
    Yildiz EP; Kilic MA; Yalcin EU; Kurekci F; Avci R; Hacıfazlıoğlu NE; Ceylaner S; Gezdirici A; Çalışkan M
    Acta Neurol Belg; 2023 Oct; 123(5):1841-1847. PubMed ID: 36094697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four Individuals with a Homozygous Mutation in Exon 1f of the
    Mroczek M; Durmus H; Töpf A; Parman Y; Straub V
    Genes (Basel); 2020 Jun; 11(7):. PubMed ID: 32605089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and genetic characterisation of a large Indian congenital myasthenic syndrome cohort.
    Polavarapu K; Sunitha B; Töpf A; Preethish-Kumar V; Thompson R; Vengalil S; Nashi S; Bardhan M; Sanka SB; Huddar A; Unnikrishnan G; Arunachal G; Girija MS; Porter A; Azuma Y; Lorenzoni PJ; Baskar D; Anjanappa RM; Keertipriya M; Padmanabh H; Harikrishna GV; Laurie S; Matalonga L; Horvath R; Nalini A; Lochmüller H
    Brain; 2024 Jan; 147(1):281-296. PubMed ID: 37721175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital myasthenic syndrome in Israel: Genetic and clinical characterization.
    Aharoni S; Sadeh M; Shapira Y; Edvardson S; Daana M; Dor-Wollman T; Mimouni-Bloch A; Halevy A; Cohen R; Sagie L; Argov Z; Rabie M; Spiegel R; Chervinsky I; Orenstein N; Engel AG; Nevo Y
    Neuromuscul Disord; 2017 Feb; 27(2):136-140. PubMed ID: 28024842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of splicing errors caused by CHRNE mutations affecting introns and intron/exon boundaries.
    Ohno K; Tsujino A; Shen XM; Milone M; Engel AG
    J Med Genet; 2005 Aug; 42(8):e53. PubMed ID: 16061559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.
    Durmus H; Shen XM; Serdaroglu-Oflazer P; Kara B; Parman-Gulsen Y; Ozdemir C; Brengman J; Deymeer F; Engel AG
    Neuromuscul Disord; 2018 Apr; 28(4):315-322. PubMed ID: 29395675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A frameshifting mutation in CHRNE unmasks skipping of the preceding exon.
    Ohno K; Milone M; Shen XM; Engel AG
    Hum Mol Genet; 2003 Dec; 12(23):3055-66. PubMed ID: 14532324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical and molecular landscape of congenital myasthenic syndromes in Austria: a nationwide study.
    Krenn M; Sener M; Rath J; Zulehner G; Keritam O; Wagner M; Laccone F; Iglseder S; Marte S; Baumgartner M; Eisenkölbl A; Liechtenstein C; Rudnik S; Quasthoff S; Grinzinger S; Spenger J; Wortmann SB; Löscher WN; Zimprich F; Kellersmann A; Rappold M; Bernert G; Freilinger M; Cetin H
    J Neurol; 2023 Feb; 270(2):909-916. PubMed ID: 36308527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Missense Mutation in Epsilon-subunit of Acetylcholine Receptor Causing Autosomal Dominant Slow-channel Congenital Myasthenic Syndrome in a Chinese Family.
    Tan JZ; Man Y; Xiao F
    Chin Med J (Engl); 2016 Nov; 129(21):2596-2602. PubMed ID: 27779167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of previously unreported mutations in CHRNA1, CHRNE and RAPSN genes in three unrelated Italian patients with congenital myasthenic syndromes.
    Brugnoni R; Maggi L; Canioni E; Moroni I; Pantaleoni C; D'Arrigo S; Riva D; Cornelio F; Bernasconi P; Mantegazza R
    J Neurol; 2010 Jul; 257(7):1119-23. PubMed ID: 20157724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
    Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.